Clinical Trial Update: Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study comparing two NN1250 insulin formulations against insulin glargine, both in combination with metformin, in adults with type 2 diabetes; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NN1250 formulation A (NN1250)
• NN1250 formulation B (NN1250)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2015-11-16